Sue Wallcraft is a member of the Audit and Risk Management Committee and the Remuneration Committee. Sue is an experienced general counsel and company secretary with over 25 years’ experience in the pharmaceutical industry and health charities. She is a qualified English solicitor and brings significant legal and governance knowledge to the board. Sue is currently General Counsel and Company Secretary for Vernalis (R&D) Limited, a non-executive director of Medicines Discovery Catapult.
Susan Wallcraft
Latest news
-
Could heart medication or arthritis drugs be used to treat motor neuron disease?
-
Accelerating innovation to transform lung health in primary care
-
LifeArc-funded trial gives new hope for children with devastating rare genetic disorder